Case Report

Diffuse Universal Hyperpigmentation Induced by Imatinib Mesylate

Sudip Kumar Ghosh^1*, Debabrata Bandyopadhyay¹, Gobinda Chatterjee¹, Arghyaprasun Ghosh¹

¹ Department of Dermatology, Venereology, and Leprosy R. G. Kar Medical College, Kolkata, West Bengal India

Anahtar Kelimeler: universal hyperpigmentationimatinib mesylate

Keywords: universal hyperpigmentationimatinib mesylate

TR PDF İndir

Abstract

ABSTRACT

Observations:

Imatinib mesylate, a tyrosine kinase inhibitor, is increasingly being used in the treatment of chronic myeloid leukemia and other oncological disorders. It may cause a large number of cutaneous adverse effects. We are reporting here a case of diffuse universal hyperpigmentation following imatinib therapy, showing lichenoid interface dermatitis on histopathology, a hitherto unreported entity.